Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01GWS
|
|||
| Drug Name |
Pyridinone compound 1
|
|||
| Synonyms |
PMID28594589-Compound-TABLE3c9
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
Asan Foundation
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H23FIN3O4
|
|||
| Canonical SMILES |
CC(C)(CONC(=O)C1=C(N(C(=O)C2=C1CCC2)C)NC3=C(C=C(C=C3)I)F)O
|
|||
| InChI |
1S/C20H23FIN3O4/c1-20(2,28)10-29-24-18(26)16-12-5-4-6-13(12)19(27)25(3)17(16)23-15-8-7-11(22)9-14(15)21/h7-9,23,28H,4-6,10H2,1-3H3,(H,24,26)
|
|||
| InChIKey |
WMBPVWDVQRPCQY-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | ERK activator kinase (MEK) | Target Info | Inhibitor | [1] |
| Target's Patent Info | ERK activator kinase (MEK) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | MEK inhibitors in oncology: a patent review (2015-Present).Expert Opin Ther Pat. 2017 Aug;27(8):887-906. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.